MicuRx Pharmaceuticals, Inc.
Biotechnology ResearchCalifornia, United States11-50 Employees
MicuRx Pharmaceuticals is a biotechnology company based out of Foster City, California USA and Shanghai, China.
Innovative R&D MicuRx Pharmaceuticals has been recognized for its pharmaceutical innovation, particularly with its contezolid tablets, indicating strong research capabilities and a focus on developing advanced antimicrobial therapies that could appeal to healthcare providers seeking cutting-edge treatments.
Strategic Funding With a recent funding round of 107 million USD led by Legend Capital and a revenue range of 50 to 100 million USD, MicuRx demonstrates solid financial backing and growth potential, making it an attractive partner for investment in novel biotech and pharmaceutical products.
Expanding Markets The company's activities span both the US and Chinese markets, including recent awards and recognition in China, which suggests a broad geographic presence and opportunities for sales expansion across diverse healthcare systems.
Focus on Refractory Conditions Developing MRX-5 for refractory NTM infections highlights an emphasis on solving unmet medical needs, presenting opportunities to connect with specialists and institutions seeking innovative solutions for difficult-to-treat infections.
Recent Industry Engagement Participation in major events like ESCMID Global 2025 and recognition for innovative health products position MicuRx as a key player in infectious disease research, making it a potential partner or supplier for clinics and hospitals looking for evidence-based, innovative treatments.
MicuRx Pharmaceuticals, Inc. uses 8 technology products and services including WordPress, Google Fonts API, yepnope.js, and more. Explore MicuRx Pharmaceuticals, Inc.'s tech stack below.
| MicuRx Pharmaceuticals, Inc. Email Formats | Percentage |
| FLast@micurx.com | 47% |
| First@micurx.com | 4% |
| Last@micurx.com | 2% |
| FLast@micurx.com | 47% |
Biotechnology ResearchCalifornia, United States11-50 Employees
MicuRx Pharmaceuticals is a biotechnology company based out of Foster City, California USA and Shanghai, China.
MicuRx Pharmaceuticals, Inc. has raised a total of $107M of funding over 8 rounds. Their latest funding round was raised on Dec 21, 2020 in the amount of $107M.
MicuRx Pharmaceuticals, Inc.'s revenue is estimated to be in the range of $50M$100M
MicuRx Pharmaceuticals, Inc. has raised a total of $107M of funding over 8 rounds. Their latest funding round was raised on Dec 21, 2020 in the amount of $107M.
MicuRx Pharmaceuticals, Inc.'s revenue is estimated to be in the range of $50M$100M